GO
Loading...

Novartis AG

More

  • Gilead: Has Bird Flu Fighter Tamiflu "Sickened" Stock? Wednesday, 17 Oct 2007 | 12:37 PM ET

    There was a time within the past couple of years that it seemed you couldn't open a major newspaper or watch a TV news program without seeing a story about the bird flu and Tamiflu--the antiviral medicine from Roche and Gilead Sciences. GILD invented the drug and later sold rights to Roche which pays GILD a royalty on sales.

  • Biogen Expected to Fetch up to $30 Billion Monday, 15 Oct 2007 | 10:11 AM ET

    Biogen Idec, which has put itself up for sale, may get bids of around $25-30 billion from several of the world's top drugmakers keen to expand in the hot area of biotech medicine.

  • Week Ahead: Earnings Tell Two Tales Friday, 12 Oct 2007 | 9:23 PM ET

    By the end of the coming week, the corporate earnings picture will be clear and it may not necessarily be one the stock market likes.

  • Drugmakers Recall Infant Cold Products Thursday, 11 Oct 2007 | 12:16 PM ET

    Johnson & Johnson , Wyeth  and other makers of infants' nonprescription cough and cold products are recalling certain medicines in the United States because of the danger of overdose, the Consumer Healthcare Products Association said Thursday.

  • Lightning Round: E*Trade, Sanofi Aventis and More Thursday, 11 Oct 2007 | 10:35 AM ET

    Cramer makes the call on viewers' favorite stocks.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Your Health, Your Trade Wednesday, 10 Oct 2007 | 11:01 PM ET

    BREAKING: Reuters reports FDA panel backs drug-coated stents made by Medtronic (MDT).

  • Novartis Says Prexige Not Approved in U.S. Thursday, 27 Sep 2007 | 9:16 AM ET

    U.S. regulators have not approved Novartis's Prexige painkiller, the Swiss drugmaker said on Thursday, in an expected move after Australia withdrew the drug due to concerns over liver side effects.

  • EU Approves of Novartis' Exelon to Treat Alzheimer's Monday, 24 Sep 2007 | 9:21 AM ET

    The drugmaker Novartis said Monday that the European Commission had approved its Exelon skin patch to treat Alzheimer's disease.

  • Novartis Bone Drug Curbs Repeat Hip Fractures Monday, 17 Sep 2007 | 11:54 PM ET

    In a study that could change the way hip fractures are treated, doctors have discovered that giving the Novartis osteoporosis drug Reclast can prevent later fractures and helps patients live longer.

  • Roche Sues Teva in U.S. Over Bone Drug Tuesday, 11 Sep 2007 | 5:08 AM ET

    Swiss drugmaker Roche Holding is taking legal action against Israel's Teva Pharmaceutical Industries in the United States to prevent Teva from selling a generic version of Roche osteoporisis drug Boniva, Roche said on Tuesday.

  • It's Time for the Lightning Round! Monday, 27 Aug 2007 | 7:31 PM ET

    American Standard, Dell, Southern Copper and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Drug Downers Thursday, 16 Aug 2007 | 3:58 PM ET
    Elvis Presley

    Thirty years ago, I was in Las Vegas. My stepmother took me to see Ann-Margret at The Hilton and I remember our waitress telling us that Elvis was the only one who could consistently pack the room. It was strange that he passed away the next day. On this, the 30th anniversary of the King's death from overdosing on prescription drugs, the stocks of the companies that make prescription drugs are having a very dark day.

  • Riding The Rally Tuesday, 31 Jul 2007 | 11:06 AM ET

    With stocks in rally mode, it's appropriate to drill down for answers as well as take a look at some key sectors.

  • Roche Holding said Thursday its CEO will step down next March as the pharmaceutical company separates that job from the chairman's position. It also posted a 24% increase in first-half net profit.

  • Novartis cut its full-year results outlook as generic competition pressured sales of a key blood-pressure drug, and said U.S. regulators had delayed the approval process for an important cancer treatment.

  • Nestle to Cut Plants, Products as Prices Soar Thursday, 12 Jul 2007 | 8:03 AM ET

    Nestle, the world's largest food company, will raise prices, cull unprofitable products and speed up production rationalization to prepare for a lasting rise in commodity and energy prices.

  • Roche has signed a deal worth up to $1 billion with Alnylam Pharmaceuticals, giving it access to the U.S. firm's skills in the new science of silencing genes to fight disease.

  • Novartis Gets EU OK for New Flu Vaccine Wednesday, 13 Jun 2007 | 4:25 AM ET

    Swiss drugmaker Novartis said Wednesday it has received European Union approval for flu vaccine Optaflu.

  • Buying Big Pharma - If You Must Tuesday, 12 Jun 2007 | 7:03 PM ET

    It’s slim pickings in the sector, but there are a couple of stocks that are actually worth buying, Cramer says.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Big Pharma Is Bad Investing Tuesday, 12 Jun 2007 | 7:00 PM ET

    Without patents or pipeline, drug companies just don't have the growth investors crave anymore. Cramer tells you who to avoid.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

Most Popular Video

Thursday, 17 Apr 2014 | 11:00 AM ET

Phil LeBeau has the details on the latest rides at this year's New York Auto Show.

Monday, 14 Apr 2014 | 11:43 AM ET

Dr. Steven Horng, Beth Israel Deaconess Medical Center, explains how Google Glass provided crucial support in an emergency situation and helped save a life.

Tuesday, 15 Apr 2014 | 11:36 PM ET

John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, expects Alibaba to push on with its buying spree after listing in the U.S.